Ординатура / Офтальмология / Английские материалы / Applied Pathology for Ophthalmic Microsurgeons_Naumann, Holbach, Kruse_2008
.pdf
Chapter
Subject Index
ACAID, see anterior-chamber-associat- |
aphakia |
23, 229, 251 |
|
|
– |
retinal barrier: see ch. 2; 4; 5.2; 5.4; |
||||||||||||||||||||
ed immune deviation |
|
|
|
apolipoprotein C |
343 |
|
|
|
5.5; 5.6; 6.3 |
|
|
|
|
|
|
|||||||||||
Acanthamoeba |
116 |
|
|
|
aponeurotic blepharoptosis |
39 |
|
blood-ocular barrier breakdown |
14 – 17 |
|||||||||||||||||
ACG, see angle closure glaucoma |
apoptosis photoreceptor death 302 |
bony orbital wall |
|
49 |
|
|
|
|||||||||||||||||||
acquired anterior chamber immune |
argon-laser |
92 |
|
|
|
|
Bowman‘s layer |
69, 76–78, 86, 98, 99, |
||||||||||||||||||
deviation (ACAID) |
77, 107 |
– iridoplasty |
169 |
|
|
|
|
109, 113, 120, 123, 135 |
|
|
||||||||||||||||
actin |
223 |
|
|
|
|
|
|
– – non-penetrating coagulation |
169 |
– interruption |
|
85 |
|
|
|
|||||||||||
Actinomyces canaliculitis |
46 |
|
arterial hypertension |
353, 378 |
|
brachytherapy |
|
312 |
|
|
|
|||||||||||||||
acute ocular hypotony |
76 |
|
|
arteriitis, giant cell |
|
342 |
|
|
brow ptosis 34 |
|
|
|
|
|
||||||||||||
adenoid cystic carcinoma of the |
arteriosclerosis |
378 |
|
|
|
Bruch‘s membrane |
257, 291, 302, 311 |
|||||||||||||||||||
lacrimal gland |
61 |
|
|
|
artificial retinal detachment |
82 |
|
brunescence of the lens |
228, 239 |
|
||||||||||||||||
adenoma |
|
|
|
|
|
|
|
asteroid hyalosis |
308 |
|
|
buckling |
305 |
|
|
|
|
|
|
|||||||
– of the ciliary pigment epithelium |
astigmatism |
72, 110 |
|
|
bulbar conjunctiva |
67 |
|
|
|
|||||||||||||||||
202 |
|
|
|
|
|
|
|
|
astrocytes |
|
278, 280, 318, 335, 339 |
|
bullous keratopathy 97, 98 |
|
|
|||||||||||
– of the non-pigmented ciliary epithe- |
atypical cyclodialysis |
150, 151 |
|
– |
and keratoplasty |
113 |
|
|
||||||||||||||||||
lium |
|
200 |
|
|
|
|
|
avascular woundhealing, cornea |
|
buphthalmus |
24, 140, 337, 339 |
|
|
|||||||||||||
age-related macular degeneration |
Avellino dystrophy |
|
111 |
|
|
bursa macularis |
256 |
|
|
|
||||||||||||||||
(AMD) |
9, 90, 247, 315 |
|
|
Axenfeld syndrome |
140, 154 |
|
bypass tube insertion |
48 |
|
|
||||||||||||||||
Alport syndrome |
229, 230 |
|
axial hyperopia |
337 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Alzheimer‘s disease |
236 |
|
|
axon |
385 |
|
|
|
|
|
|
CALT, see conjunctiva-associated |
|
|||||||||||||
amblyopia |
231 |
|
|
|
|
|
bacterial endophthalmitis 19 |
|
|
lymphatic tissue |
|
|
|
|
||||||||||||
AMD, see age-related macular degener- |
|
canaliculo-dacryocystorhinostomy |
|
|||||||||||||||||||||||
ation |
|
|
|
|
|
|
|
balloon cells |
297 |
|
|
|
|
|
47 |
|
|
|
|
|
|
|
||||
aminoglycoside |
302 |
|
|
|
basal cell carcinoma of the eyelid |
41 |
canthal tendon |
|
37 |
|
|
|
||||||||||||||
amniotic membrane transplantation |
basal lamina |
307 |
|
|
|
|
capsule contraction syndrome |
249 |
||||||||||||||||||
75, 125 |
|
|
|
|
|
|
|
basal linear deposits |
291 |
|
|
capsulectomy, anterior |
251 |
|
|
|||||||||||
– conjunctiva |
73, 74 |
|
|
|
basement membrane deposit |
291 |
|
capsulopalpebral fascia |
32 |
|
|
|||||||||||||||
angioblast |
318 |
|
|
|
|
|
Bell‘s phenomenon |
33 |
|
|
capsulorrhexis |
|
93, 219, 226, 228, 251 |
|||||||||||||
angle closure glaucoma (ACG) |
136, |
Berger‘s space |
95, 221, 226, 255 |
|
cataract 234, 244 |
|
|
|
|
|||||||||||||||||
137, 158, 340, 371 |
|
|
|
Bergmeister disc |
256 |
|
|
– |
age-related |
235 |
|
|
|
|||||||||||||
– after vitreoretinal surgery |
319 |
bevacizumab |
121 |
|
|
|
|
– |
congenital |
235 |
|
|
|
|
||||||||||||
angular |
|
|
|
|
|
|
|
Bick procedure |
36 |
|
|
|
– – visual deprivation |
378 |
|
|
||||||||||
– artery |
32 |
|
|
|
|
|
bilateral orbital metastases |
60 |
|
– |
diabetic |
351 |
|
|
|
|
|
|||||||||
– vein |
32 |
|
|
|
|
|
|
biocytology |
7 |
|
|
|
|
|
– etiology |
235 |
|
|
|
|
|
|||||
aniridia |
154, 234 |
|
|
|
|
biphakia |
229 |
|
|
|
|
|
– |
extraction |
8, 217 |
|
|
|
||||||||
annulus of Zinn |
50 |
|
|
|
black ball hyphema |
145 |
|
|
– – extracapsular |
170, 245, 351, 373 |
||||||||||||||||
anophthalmic socket surgery |
65 |
blepharoplasty |
32, 34, 40 |
|
|
– – intracapsular |
|
91, 246 |
|
|
||||||||||||||||
anterior |
|
|
|
|
|
|
|
blepharoptosis |
33, 34, 59, 61 |
|
– – wound rupture |
87 |
|
|
|
|||||||||||
– chamber |
|
|
|
|
|
|
– aponeuritic |
39 |
|
|
|
|
– formation |
236, 319 |
|
|
|
|||||||||
– – cleavage syndrome |
154 |
|
– mechanical |
39 |
|
|
|
|
– iatrogenic traumatic |
93 |
|
|
||||||||||||||
– – hypoxia |
367 |
|
|
|
|
– myogenic |
39, 40 |
|
|
|
– intumescent |
|
79 |
|
|
|
||||||||||
– extraperiostal orbitotomy |
65 |
– neurogenic |
39 |
|
|
|
|
– nuclear |
211 |
|
|
|
|
|
||||||||||||
– transconjunctival orbitotomy 64 |
blepharotomy |
63, 65 |
|
|
– after vitrectomy |
318 |
|
|
||||||||||||||||||
– transseptal orbitotomy |
64 |
|
Blessig-Ivanoff cyst |
272 |
|
|
– optical coherence tomography |
244 |
||||||||||||||||||
– uvea |
|
|
|
|
|
|
|
|
blindness, bilateral |
|
289 |
|
|
– |
surgery |
3, 182, 225 |
|
|
|
|||||||
– – malignant melanoma |
190, 196 |
block-excision |
|
|
|
|
|
– – complications |
246 |
|
|
|
||||||||||||||
– – tumors |
177 |
|
|
|
|
|
– tumors, iris-root and ciliary body |
– – wound healing |
246 |
|
|
|||||||||||||||
anterior-chamber-associated immune |
see ch. 5.3; 5.4 |
|
|
|
|
– ultrasound biomicroscopy 244 |
|
|||||||||||||||||||
deviation (ACAID) |
105 |
|
|
– epithelial ingrowth in chamber |
|
cataracta |
|
|
|
|
|
|
|
|||||||||||||
antigen-presenting cell (APC) |
97 |
angle |
see ch. 5.3; 5.4 |
|
|
– |
calcarea |
241 |
|
|
|
|
|
|||||||||||||
antiglaucomatous iridotomy |
3 |
blood-aqueous barrier 14 – 17 |
|
– matura |
241 |
|
|
|
|
|
||||||||||||||||
antithrombin III defect |
343 |
|
– ciliary body |
16 |
|
|
|
cavernous hemangioma of the orbit |
55 |
|||||||||||||||||
APC, see antigen-presenting cell |
– iris |
15 |
|
|
|
|
|
|
cavernous optic nerve atrophy |
131 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subject Index |
393 |
||
dacryocystorhinostomy external 46, |
electroretinography (ERG) |
300 |
|
– normal function |
7 |
|
|
|
|
|
|
||||||||||||||||||||
|
47 |
|
|
|
|
|
|
|
Elliot‘s principle |
145 |
|
|
|
|
– |
size |
|
94 |
|
|
|
|
|
|
|
|
|
||||
– endonasal |
48 |
|
|
|
ELM, see external limiting membrane |
– transcorneal access |
|
76 |
|
|
|
||||||||||||||||||||
dacryolithiasis |
46 |
|
|
Elschnig‘s |
|
|
|
|
|
|
|
|
eyelid |
|
|
|
|
|
|
|
|
|
|
|
|||||||
DALK, see deep anterior lamellar |
– pearls |
248, 249 |
|
|
|
|
|
– basal cell carcinoma |
|
41 |
|
|
|
||||||||||||||||||
|
keratoplasty |
|
|
|
|
– |
scleral ring |
35, 335, 338, 340 |
|
– |
cicatricial entropion |
|
37 |
|
|
|
|||||||||||||||
daunomycin |
302 |
|
|
– spur 26, 346 |
|
|
|
|
|
|
– disorders of position and movement |
|
|||||||||||||||||||
daunorubicin |
315 |
|
|
embryotoxon |
140 |
|
|
|
|
|
|
33 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
deep anterior lamellar keratoplasty |
EMZL, see extranodal marginal zone |
– extraocular surgery |
|
11 |
|
|
|
||||||||||||||||||||||||
|
(DALK) |
100, 123 |
|
|
|
B-cell lymphoma |
|
|
|
|
|
– fat pads |
32 |
|
|
|
|
|
|
|
|||||||||||
degenerative |
|
|
|
|
|
endonasal dacrycystorhinostomy |
48 |
– |
full-thickness defect |
|
44 |
|
|
|
|||||||||||||||||
– |
fibrillopathy |
355 |
|
|
endophthalmitis |
14, 19, 149, 247 |
– |
involutional entropion |
37 |
|
|
|
|||||||||||||||||||
– retinoschisis |
262 |
|
|
– hemogranulomatosa |
24, 315 |
|
– laxity |
33, 34 |
|
|
|
|
|
|
|
||||||||||||||||
dentritic melanocytes 153 |
– |
phacoanaphylactica |
5, 244, 245 |
– |
lower retractor |
32 |
|
|
|
|
|
|
|||||||||||||||||||
dermatochalasis |
39, 40 |
|
– postoperative |
76, 252 |
|
|
|
– Merkel cell carcinoma |
43 |
|
|
|
|||||||||||||||||||
dermoid cyst of the orbit |
51, 52, 64 |
– purulent |
18 |
|
|
|
|
|
|
– nodular tumefaction |
|
60 |
|
|
|
||||||||||||||||
Descemet‘s |
|
|
|
|
|
endoresection 312 |
|
|
|
|
|
– sebaceous gland carcinoma |
|
40, 42 |
|
||||||||||||||||
– membrane |
100, 113, 123, 174, 371 |
endothelial cells |
101 |
|
|
|
|
– skin |
|
30 |
|
|
|
|
|
|
|
|
|
||||||||||||
– – defects |
85 |
|
|
|
enucleation |
66 |
|
|
|
|
|
|
– squamous cell carcinoma |
42 |
|
||||||||||||||||
– stripping automated lamellar |
entropion |
34, 37 |
|
|
|
|
|
– surgery |
65 |
|
|
|
|
|
|
|
|||||||||||||||
|
endothelial keratoplasty (DSAEK) |
– |
cicatricial, of the lower lid |
37 |
– |
surgical anatomy |
30 |
|
|
|
|
||||||||||||||||||||
|
124 |
|
|
|
|
|
|
|
– |
involutional, of the lower lid |
|
37 |
– |
tumors |
39, 40 |
|
|
|
|
|
|
|
|||||||||
dexamethasone |
315 |
|
– of the upper lid 38 |
|
|
|
|
– upper retractor |
31 |
|
|
|
|
|
|
||||||||||||||||
diabetes mellitus |
237, 351, 378 |
epiphora |
46 |
|
|
|
|
|
|
– |
veins |
|
32 |
|
|
|
|
|
|
|
|
||||||||||
diabetic |
|
|
|
|
|
|
|
epiretinal membrane |
|
279 |
|
|
eye-wall sclera, mechanical loci |
|
|
||||||||||||||||
– |
cataract |
351 |
|
|
|
episclera/episcleral |
|
|
|
|
|
|
minores resistentiae |
|
|
86 |
|
|
|
||||||||||||
– cystoid maculopathy |
307 |
– melanocytosis |
72 |
|
|
|
|
|
facial nerve |
|
32 |
|
|
|
|
|
|
|
|||||||||||||
– iridopathy |
157, 159, 351 |
– |
pigmented findings |
72 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
– |
retinopathy |
281, 287, 305, 351 |
epithelial |
|
|
|
|
|
|
|
|
factor V Leyden defect |
|
|
343 |
|
|
|
|||||||||||||
diaphanoscopy |
178 |
|
|
– hemidesmosomes |
125 |
|
|
|
familial exudative vitreoretinopathy |
|
|||||||||||||||||||||
diathermy |
25, 213 |
|
|
– ingrowth: see block-excision |
|
|
(FEVR) |
268, 269, 290 |
|
|
|
||||||||||||||||||||
– transscleral |
76 |
|
|
– melanosis |
72 |
|
|
|
|
|
|
FasL 259 |
|
|
|
|
|
|
|
|
|
||||||||||
diffuse large B-cell lymphoma |
epitheloid cells |
297 |
|
|
|
|
|
Fenestration of the oveal sheath |
342 |
|
|||||||||||||||||||||
|
(DLBCL) |
298 |
|
|
|
equatorial sclera |
86 |
|
|
|
|
|
FGF, see fibroblast growth factor |
|
|||||||||||||||||
diffuse malignant melanoma |
ERG, see electroretinography |
|
|
fibrillin |
|
225 |
|
|
|
|
|
|
|
|
|||||||||||||||||
– |
iris |
see ch. 5.3; 5.4; 5.6 |
Erlangen sketch |
77 |
|
|
|
|
|
– |
fibrillin-1 gene |
232 |
|
|
|
|
|
||||||||||||||
– |
uvea |
see ch. 5.3; 5.4 |
|
ethmoidal |
|
|
|
|
|
|
|
|
fibrillogenesis, fibrillopathy |
355 |
|
||||||||||||||||
– |
block excision-contraindication |
– |
nerve |
50 |
|
|
|
|
|
|
|
fibrin |
74, 109 |
|
|
|
|
|
|
|
|||||||||||
|
see ch. 5.3; 5.4; 5.6 |
|
|
– |
vessel |
50 |
|
|
|
|
|
|
|
fibroblast |
285 |
|
|
|
|
|
|
|
|||||||||
dilatator pupillae |
153 |
|
evisceration |
66 |
|
|
|
|
|
|
– |
growth factor (FGF) |
|
316 |
|
|
|
||||||||||||||
diplopia |
303 |
|
|
|
|
excavation 131 |
|
|
|
|
|
|
fibrocytes |
317 |
|
|
|
|
|
|
|
||||||||||
disc, optic – at risk |
337 |
|
excimer laser trephination cornea |
fibronectin |
306 |
|
|
|
|
|
|
|
|||||||||||||||||||
– drusen |
337 |
|
|
|
|
|
126 |
|
|
|
|
|
|
|
|
fibrosis |
|
248 |
|
|
|
|
|
|
|
|
|||||
disciforme keratitis |
116 |
|
exenteration of the orbit |
66 |
|
|
fibrous |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
dislocation of the clear lens 8 |
exfoliation syndrome: see pseudo- |
– |
astrocytes |
278 |
|
|
|
|
|
|
|
||||||||||||||||||||
distichiasis |
31, 39 |
|
|
|
exfoliation syndrome (PEX) |
|
|
– pseudo-metaplasia |
|
239 |
|
|
|
||||||||||||||||||
DLBCL, see diffuse large B-cell |
exophthalmometry |
33 |
|
|
|
fish-hook technique |
91 |
|
|
|
|
||||||||||||||||||||
|
lymphoma |
|
|
|
|
expulsive choroidal hemorrhage |
17, |
fistula |
|
17 |
|
|
|
|
|
|
|
|
|
||||||||||||
dot hemorrhage |
283 |
|
|
18 |
|
|
|
|
|
|
|
|
FLA, see fluorescein angiography |
|
|||||||||||||||||
drusen retinal |
291 |
|
|
exsiccosis |
145 |
|
|
|
|
|
|
flame hemorrhage |
283 |
|
|
|
|
||||||||||||||
drusen of the optic disc |
338 |
exsudative retinal detachment |
82 |
flap tear |
262 |
|
|
|
|
|
|
|
|||||||||||||||||||
drusinosis retinal |
343 |
|
external limiting membrane (ELM) |
Fleischer ring |
113 |
|
|
|
|
|
|
||||||||||||||||||||
dry eye |
|
68, 74, 75, 102, 116 |
|
278 |
|
|
|
|
|
|
|
|
Flexner-Wintersteiner rosettes |
299, |
|
||||||||||||||||
DSAEK, see Descemet’s stripping |
extracapsular cataract extraction |
351, |
|
313 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
automated lamellar endothelial |
|
373 |
|
|
|
|
|
|
|
|
floppy eyelid syndrome |
|
34. 35 |
|
|
|||||||||||||||
|
keratoplasty |
|
|
|
|
extranodal marginal zone B-cell |
|
fluorescein angiography (FLA) |
343 |
|
|||||||||||||||||||||
dystrophy of corneal endothelium |
|
lymphoma (EMZL) |
298 |
|
|
5-fluorouracil |
147, 150, 302 |
|
|
|
|||||||||||||||||||||
|
113 |
|
|
|
|
|
|
|
extraocular, see also intraocular |
|
follicular hypertrophy of the conjunctiva |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
surgery |
|
|
|
|
|
|
|
|
|
68 |
|
|
|
|
|
|
|
|
|
|
|
Eales disease |
281, 285, 289 |
– |
muscle |
50 |
|
|
|
|
|
|
foveola |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
ectopia lentis |
232 |
|
|
– – surgery |
65 |
|
|
|
|
|
|
– |
cleft |
|
256 |
|
|
|
|
|
|
|
|
||||||||
ectropion |
34, 46 |
|
|
|
– |
solid tumor |
|
|
|
|
|
|
– |
slit |
8 |
|
|
|
|
|
|
|
|
|
|||||||
– |
cicatricial |
36, 37 |
|
|
– – choroidal metastases |
297 |
|
|
Fuchs‘ |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
– involutional |
36 |
|
|
exudative retinal detachment |
266, |
– adenoma |
|
186 |
|
|
|
|
|
|
|
||||||||||||||||
– paralytical |
36, 37 |
|
|
268 |
|
|
|
|
|
|
|
|
– |
corneal dystrophy |
113 |
|
|
|
|||||||||||||
effusion, aveal |
see ch. 2; 4; 5.1; 5.5 |
eye |
|
|
|
|
|
|
|
|
– |
dystrophy |
92, 97, 98, 374, 101, 372 |
|
|||||||||||||||||
Egger‘s line |
226 |
|
|
|
– blunt trauma |
183 |
|
|
|
|
|
– heterochromia |
178 |
|
|
|
|
|
|||||||||||||
elastic microfibrils |
355 |
|
– |
high myopic |
94 |
|
|
|
|
|
– |
roll |
|
92, 93, 134, 143, 153, 169 |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subject Index |
395 |
||
– |
root |
169, 171, 172, 187 |
|
|
lacrimal |
|
|
|
|
|
|
|
– |
fibers |
223, 224, 241 |
|
|
|
|
||||||||||||
– – involvement in epithelial in- |
– artery |
32 |
|
|
|
|
|
– – aging changes |
|
227 |
|
|
|
||||||||||||||||||
|
growth |
see 5.3; 5.4 |
|
|
|
– drainage system |
45 |
|
|
– intraocular implant (IOL) |
225 |
|
|||||||||||||||||||
– – rhabdomyosarcoma |
192 |
|
– – surgical anatomy |
45 |
|
– metabolism |
300 |
|
|
|
|
|
|||||||||||||||||||
– – tumors and block-excision |
see |
– gland |
50 |
|
|
|
|
|
– microsurgery |
219 |
|
|
|
|
|||||||||||||||||
|
5.3; 5.4 |
|
|
|
|
|
|
|
– – adenoid cystic carcinoma |
61 |
– |
opacities |
8, 360 |
|
|
|
|
|
|||||||||||||
– sectorial ischemic necrosis |
159 |
– – biopsy |
65 |
|
|
|
|
– |
proteins |
241 |
|
|
|
|
|
|
|||||||||||||||
– sphincterotomy |
374 |
|
|
|
– – pleomorphic adenoma 62 |
– pseudophacic implants 220 |
|
|
|||||||||||||||||||||||
– stroma |
154, 171 |
|
|
|
– nerve |
33 |
|
|
|
|
|
– subluxation |
151, 360 |
|
|
|
|||||||||||||||
– – circumscribed defects |
172 |
|
– sac |
45 |
|
|
|
|
|
|
– surgical anatomy |
220 |
|
|
|
||||||||||||||||
– – crypts |
367 |
|
|
|
|
|
– – oncocytoma |
47 |
|
|
|
– suspensory ligament |
225 |
|
|
|
|||||||||||||||
– surgical anatomy |
153 |
|
|
– – tumors |
46 |
|
|
|
|
– traumatic luxation |
234 |
|
|
|
|||||||||||||||||
– suture |
172 |
|
|
|
|
|
– surgery |
47 |
|
|
|
|
|
– zonules |
|
|
|
|
|
|
|
|
|
||||||||
– synechia |
14 |
|
|
|
|
|
lamellar keratoplasty |
121, 123 |
– – aging changes |
|
227 |
|
|
|
|||||||||||||||||
– tumors |
161, 162, 171 |
|
|
|
lamina |
|
|
|
|
|
|
|
lens-induced uveitis |
232 |
|
|
|
||||||||||||||
– vessel |
173 |
|
|
|
|
|
– |
cribrosa |
86 |
|
|
|
|
lens-iris diaphragm |
219, 371 |
|
|
|
|||||||||||||
– – hemorrhage |
173 |
|
|
|
– elastica interna |
342 |
|
|
lentectomy |
309 |
|
|
|
|
|
|
|||||||||||||||
– wound healing 164 |
|
|
|
– papyracea |
49 |
|
|
|
|
lenticonus |
230 |
|
|
|
|
|
|
||||||||||||||
iris-lens diaphragm |
13, 94, 360 |
laminin |
306, 307 |
|
|
|
lenticular opacification |
234 |
|
|
|
||||||||||||||||||||
ischemia |
281, 310 |
|
|
|
|
landmarks |
|
|
|
|
|
|
lentiglobus |
230 |
|
|
|
|
|
|
|||||||||||
– damage to endothelial cells |
282 |
– for gonioscopy |
131 |
|
|
leukokoria |
299 |
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
– |
for surgical corneal limbus |
135 |
leukoplakia of the conjunctiva |
70 |
|
||||||||||||||||
jaw winking phenomenon |
33 |
|
Langerhans-cell histiocytosis of the |
levator aponeurosis |
31, 49, 65 |
|
|
||||||||||||||||||||||||
Jünemann line |
114 |
|
|
|
|
orbit |
54 |
|
|
|
|
|
|
lid, see eyelid |
|
|
|
|
|
|
|
|
|||||||||
juvenile |
|
|
|
|
|
|
|
|
laser |
|
|
|
|
|
|
|
|
ligneous conjunctivitis |
74 |
|
|
|
|||||||||
– |
retinoschisis |
258 |
|
|
|
– |
in situ keratomileusis (LASIK) 102, |
limbus/limbal |
|
107, 135 |
|
|
|
||||||||||||||||||
– rheumatoid arthritis |
246 |
|
|
116, 123, 126 |
|
|
|
|
– corneae |
86 |
|
|
|
|
|
|
|
||||||||||||||
– |
uveitis |
246 |
|
|
|
|
|
– |
iridotomy |
92, 93, 143, 159, 173, 174 |
– |
corneoscleral |
107 |
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
– photocoagulation |
302 |
|
– definition |
109 |
|
|
|
|
|
|
|||||||||||
keratectomy |
3, 108 |
|
|
|
– |
trabeculoplasty |
3, 144 |
|
– |
lymphatic vessel |
|
101 |
|
|
|
||||||||||||||||
– photorefractive (PRK) |
98 |
|
– trephination in PKP |
see ch. 5.1 |
– macrophage |
101 |
|
|
|
|
|||||||||||||||||||||
keratin |
107, 111, 125 |
|
|
|
– |
tyndallometry |
119, 166, 244, 347 |
– |
perforation |
|
81 |
|
|
|
|
|
|
||||||||||||||
keratitis |
115, 116 |
|
|
|
|
LASIK, see laser in situ keratomileusis |
– |
stem cells (SCs) |
|
107 |
|
|
|
||||||||||||||||||
– herpetic |
116 – 118 |
|
|
|
– complications |
127 |
|
|
– – transplantation |
109, 116, 125 |
|
||||||||||||||||||||
– immune reaction |
119 – 121 |
|
– Reinervation cornea after surgery |
– surgical anatomy |
97 |
|
|
|
|||||||||||||||||||||||
– mycotic |
87 |
|
|
|
|
|
|
127 |
|
|
|
|
|
|
|
|
– vascular arcade |
|
101 |
|
|
|
|||||||||
– necrotizing |
|
87, 117 |
|
|
|
lateral |
|
|
|
|
|
|
|
|
– wound |
84 |
|
|
|
|
|
|
|
|
|||||||
– – stromal |
|
116 |
|
|
|
|
– orbitotomy |
65 |
|
|
|
LIPCOF sign |
74 |
|
|
|
|
|
|
||||||||||||
– neurotrophic |
117 |
|
|
|
– |
tarsal strip procedure |
36 |
|
lipid keratopathy |
114 |
|
|
|
|
|||||||||||||||||
– |
superior limbal |
74 |
|
|
|
lattice |
|
|
|
|
|
|
|
|
lipofuscin |
314, 340 see also ch. 4; |
|
||||||||||||||
keratoconjunctivitis, vernal |
116 |
– |
degeneration |
260, 261 |
|
|
5.1 |
|
|
|
|
|
|
|
|
|
|
||||||||||||||
keratoconus |
101, 113 |
|
|
|
– dystrophy |
111 |
|
|
|
– and other ocular pigments |
|
|
|
||||||||||||||||||
– acute |
113 |
|
|
|
|
|
|
– – type II (Meretoja form) |
112 |
– cornea |
114 – 115 |
|
|
|
|
||||||||||||||||
keratocyte |
126 |
|
|
|
|
lax eyelid syndrome |
34 |
|
|
Lisch‘s dystrophy |
110, 111 |
|
|
|
|||||||||||||||||
keratoepithelin gene 110 |
|
|
Leber‘s hemorrhagic lymphangiectasia |
Lockwood‘s suspensory ligament |
32 |
|
|||||||||||||||||||||||||
keratoglobus |
113 |
|
|
|
|
|
70 |
|
|
|
|
|
|
|
|
long anterior zonule syndrome |
228 |
|
|||||||||||||
keratokonus, avascular wound healing |
Lee syndrome |
92 |
|
|
|
lymphangiogenesis |
67, 103, 104, 114 |
|
|||||||||||||||||||||||
|
119 |
|
|
|
|
|
|
|
|
leiomyoma |
|
|
|
|
|
|
lymphangioma |
|
|
|
|
|
|
|
|||||||
keratopathy |
|
63 |
|
|
|
|
– of the choroid |
203 |
|
|
– of the conjunctiva 67, 70 |
|
|
|
|||||||||||||||||
– |
bullous |
92, 97, 98 |
|
|
|
– |
of the ciliary body |
203, 204 |
– |
of the orbit |
|
55 |
|
|
|
|
|
|
|||||||||||||
– |
lipid |
115 |
|
|
|
|
|
|
leitstructuren |
|
|
|
|
|
lymphatic endothelial marker |
67, 68 |
|
||||||||||||||
– neurotrophic |
116 |
|
|
|
– horizontal |
|
|
|
|
|
lymphatic vessel |
115 |
|
|
|
|
|||||||||||||||
– pseudoexfoliation syndrome |
|
– vertical |
|
|
|
|
|
|
lymphoma |
309 |
|
|
|
|
|
|
|||||||||||||||
|
(PEX) |
92 |
|
|
|
|
|
|
lens |
217 |
|
|
|
|
|
|
macrophthalmus |
337 |
|
|
|
|
|||||||||
keratoplasty |
38, 79, 100, 126 |
|
– aging changes |
226 |
|
|
|
|
|
|
|||||||||||||||||||||
– DSAEK |
123 – 124 |
|
|
|
– anatomy |
217 |
|
|
|
|
macular |
|
|
|
|
|
|
|
|
|
|
||||||||||
– Excimer laser |
121 – 123 |
|
|
– brunescence 228 |
|
|
|
– corneal dystrophy (MCD) |
112 |
|
|||||||||||||||||||||
– lamellar |
121, 123 – 125 |
|
|
– capsule |
93, 219, 221, 227, 243, 354 |
– edema |
280, 309, 319 |
|
|
|
|||||||||||||||||||||
– low risk |
115, 126 |
|
|
|
– – aging changes |
227 |
|
|
– hole |
273, 276, 278 |
|
|
|
|
|||||||||||||||||
– penetrating |
90, 105, 110, 113, 121, |
– – posterior |
94 |
|
|
|
|
– – impending |
280 |
|
|
|
|
||||||||||||||||||
|
125 |
|
|
|
|
|
|
|
|
– – true exfoliation |
243 |
|
– – traumatic |
279 |
|
|
|
|
|
||||||||||||
– – reinnervation |
126 |
|
|
|
– coloboma-like defect |
229, 232 |
– pucker |
276, 281 |
|
|
|
|
|
||||||||||||||||||
– |
perforating |
|
117, 174, 87 |
|
|
– |
dislocations |
232 |
|
|
|
– |
retinoschisis |
344 |
|
|
|
|
|||||||||||||
keratotorus |
|
113 |
|
|
|
|
– – isolated |
232 |
|
|
|
|
– |
star |
193 |
|
|
|
|
|
|
|
|
||||||||
keratouveitis, herpetic |
92 |
|
|
– |
duplication |
229 |
|
|
|
– |
translocation |
311 |
|
|
|
|
|||||||||||||||
Kranenburg‘s syndrome |
337, 344 |
– epithelium |
220, 222, 223, 239 |
maculopathy |
|
|
|
|
|
|
|
|
|||||||||||||||||||
krypton laser |
92 |
|
|
|
|
– – aging changes |
227 |
|
|
– cystoid |
90, 95, 151, 247 |
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
– equator |
92 |
|
|
|
|
|
– – diabetic |
307 |
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subject Index |
397 |
|
– lymphangioma |
55 |
|
|
phacodonesis |
8, 92, 360, 374 |
|
pseudoadenomatous hyperplasia |
186 |
|
||||||||||
– marginal-zone B-cell lymphoma 59 |
phacoemulsification |
3, 18, 91, 147, |
pseudocavernous optic neuropathy |
|
|||||||||||||||
– neurilemmoma (schwannoma) |
58 |
217, 245, 251 |
|
|
|
347 |
|
|
|
|
|
|
|||||||
– periocular xanthogranuloma |
60 |
phacogenic uveitis |
244, 245 |
|
pseudoexfoliation (PEX) |
|
|
|
|||||||||||
– rhabdomyosarcoma |
51, 53 |
|
phacolytic glaucoma |
244 |
|
– endotrabecular material 368 |
|
|
|||||||||||
– solitary fibrous tumor 57 |
|
phakomatosis |
5, 338 |
|
|
– fiber formation |
|
357 |
|
|
|
||||||||
– superior fissure |
50 |
|
|
photocoagulation |
313 |
|
– fibrils 362 |
|
|
|
|
|
|
||||||
– surgical anatomy 49 |
|
– panretinal |
309 |
|
|
|
– glaucoma |
368 |
|
|
|
|
|
||||||
– tumors |
50 |
|
|
|
|
photoreceptor |
|
|
|
– hydropathy |
360 |
|
|
|
|
||||
– – excisional biopsy |
62 |
|
– outer segment (POS) 316 |
|
– iridopathy |
159, 178 |
|
|
|
||||||||||
– – incisional biopsy |
62 |
|
– pigment epithelial interface 258, |
– – aqueous flare |
359 |
|
|
|
|||||||||||
– – surgery |
64 |
|
|
|
|
266 |
|
|
|
|
|
– – laser-tyndallometry |
359 |
|
|
||||
orbitopathy, thyroid-associated |
62 |
photorefractive keratectomy (PRK) |
3, |
– keratopathy |
92, 113, 371, 372, 373 |
|
|||||||||||||
orbitotomy |
57 |
|
|
|
|
98 |
|
|
|
|
|
– syndrome |
8, 92, 94, 101, 138, 156, |
|
|||||
– anterior |
|
|
|
|
|
phototoxic damage |
93 |
|
171, 193, 220, 225, 233, 237, 243, 246, |
|
|||||||||
– – extraperiostal |
65 |
|
|
PHPV, see persistent hyperplastic |
|
351, 354 |
|
|
|
|
|
|
|||||||
– – transconjunctival |
64 |
|
primary vitreous |
|
|
|
– – asymmetry of involvement |
359 |
|
||||||||||
– – transseptal |
64 |
|
|
phthisis bulbi |
305 |
|
|
|
– – corneal involvement |
371 |
|
|
|||||||
– lateral |
65 |
|
|
|
|
|
physiological pupillary resistance |
92 |
– – genetic: LoxL1 |
|
357 |
|
|
|
|||||
outer limiting membrane (OLM) |
257 |
pigmented ciliary cyst |
83 |
|
– – glaucome |
371 |
|
|
|
|
|||||||||
|
|
|
|
|
|
|
pilocarpine |
154 |
|
|
|
– – iris involvement |
364, 365 |
|
|
||||
painful blind eye |
|
65 |
|
|
pilocytic astrocytoma |
346 |
|
– – masked 359 |
|
|
|
|
|
||||||
palisades of Vogt |
|
97, 99, 107, 110 |
PIOL, see primary intraocular lympho- |
– – pathobiology |
355 |
|
|
|
|||||||||||
panretinal photocoagulation 308, 309 |
ma |
|
|
|
|
|
– – pathogenetic concept |
355 |
|
|
|||||||||
papilledema |
11, 193 |
|
|
platelet-derived growth factor |
|
– – surgical pathology 360 |
|
|
|||||||||||
papillophlebitis |
343 |
|
|
(PDFG) |
316, 318 |
|
|
– – trabecular meshwork |
368 |
|
|
||||||||
paracentesis effect |
14, 91; also ch. 5.2; |
pleomorphic adenoma of the lacrimal |
pseudoglaucomatous |
|
|
|
|||||||||||||
5.5; 5.6; see blood-ocular barriers: |
gland |
62 |
|
|
|
|
– macroexcavation |
337 |
|
|
|
||||||||
aqueous and retinal |
|
|
PMMA, see polymethylmethacrylate |
– optic atrophy |
342 |
|
|
|
|||||||||||
paralytic ectropion |
36, 37 |
|
POAG, see primary open angle |
|
pseudoglioma |
267, 289 |
|
|
|
||||||||||
pars |
|
|
|
|
|
|
glaucoma |
|
|
|
|
pseudohypopyon |
299 |
|
|
|
|||
– plana |
225 |
|
|
|
|
polygeny |
110 |
|
|
|
pseudometaplastic epithelial cells |
|
|||||||
– – cyst |
83, 90, 178, 256 |
|
polymethylmethacrylate (PMMA) |
3, |
240 |
|
|
|
|
|
|
||||||||
– – transscleral approach |
90 |
216 |
|
|
|
|
pseudonormal mini-cups 337 |
||||
– – vitrectomy |
3, 91, 95, 193, 247, 301, |
polyneuropathy |
112 |
|
|
pseudo-operculum |
278 |
|
|||
305, 308, 309, 343 |
|
polyphenotypia |
110 |
|
|
pseudophakia |
247, 251, 304 |
|
|||
– plicata 92, 164, 176 |
|
POS, see photoreceptor outer segment |
pseudophakic accomodation |
182, |
|||||||
PAS-positive |
|
|
post-detachment pucker |
280 |
|
252 ff. |
|
|
|
||
– inner limiting membrane 305 |
posterior |
|
|
|
|
pseudophakos |
216, 217, 252 |
|
|||
– rhabdomyoblast 165 |
|
– capsule opacification (PCO) |
247 |
pseudo-rosettes |
299 |
|
|||||
paternoster phenomenon |
153 |
– – fibrosis-type |
248 |
|
|
pseudotumor cerebri (PTC) |
347 |
||||
PCNSL, see primary central nervous |
– – pearl-type |
|
249 |
|
|
pseudouveitis |
367 |
|
|
||
system lymphoma |
|
– – prevention |
|
251 |
|
|
PTC, see pseudotumor cerebri |
||||
PCO, see posterior capsule opacification |
– – treatment |
251 |
|
|
pterygium of the conjunctiva |
72 |
|||||
PDFG, see platelet-derived growth |
– ciliary artery occlusion |
286 |
|
pupillary block |
17, 18 |
|
|||||
factor |
|
|
– synechiae |
171 |
|
|
purulent |
|
|
|
|
penetrating keratoplasty |
26, 90, 105, |
– vitreous detachment (PVD) |
278 |
– endophthalmitis |
18 |
|
|||||
110, 113, 121, 125 |
|
postkeratoplasty neovascularization |
– panophthalmitis |
19 |
|
||||||
– reinnervation |
126 |
|
116, 121, 123, 126 |
|
|
PVR, see proliferative vitreoretinopathy |
|||||
perfluorocarbon liquid |
301 |
postoperative endophthalmitis |
76; |
|
|
|
|
|
||||||
perforating keratoplasty |
87, 117, 174 |
also ch. 2; 4; 5.1; 5.2; 5.5; 5.6 |
|
Quickert procedure |
37 |
|
|
|||||||
pericytes dropout |
284 |
|
preretinal vascularization |
9 |
|
|
|
|
|
|
||||
periocular xanthogranuloma of the |
presbyopia |
182, 227, 245 |
|
|
radial optic neurotomy (RONT) 343 |
|||||||||
orbit |
60 |
|
|
|
|
primary |
|
|
|
radiation |
|
|
|
|
periorbita |
50 |
|
|
|
– acquired melanosis 73 |
|
– opticoneuropathy (RONP) |
347 |
||||||
peripheral |
|
|
|
|
– central nervous system lymphoma |
– retinopathy |
289 |
|
|
|
||||
– microcystoid degeneration 262 |
(PCNSL) |
298 |
|
|
Radius-Maumenee syndrome |
138, |
||||||||
– retinal hole |
263 |
|
|
– intraocular lymphoma (PIOL) |
298 |
139, 146 |
|
|
|
|
||||
peripupillary iris pigment epitheli- |
– open angle glaucoma (POAG) |
138, |
ragged red fiber |
34 |
|
|
|
|||||||
um 359 |
|
|
|
|
144, 368 |
|
|
|
RAM, see relative anterior microph- |
|||||
peritomy, conjunctival |
108 |
PRK, see photorefractive keratectomy, |
thalmus |
|
|
|
|
|||||||
perlecan |
307 |
|
|
|
-Haze after 100 |
|
|
reactive polyclonal lymphofollicular |
||||||
persistent hyperplastic primary |
progressive endophthalmitis 150 |
hyperplasia of the orbit |
60 |
|
||||||||||
vitreous (PHPV) |
230, 231 |
proliferative vitreoretinopathy (PVR) |
Reis-Bückler‘s dystrophy |
111 |
|
|||||||||
Peters’ anomaly |
140, 141, 154, 171 |
94, 314, 305 |
|
|
relative anterior microphthalmus |
|||||||||
Petit‘s canal |
255 |
|
|
proptosis |
58, 59 |
|
|
(RAM) 94, 139 |
|
|
|
|||
PEX, see pseudoexfoliation |
– differential diagnosis |
62 |
|
relaxing retinotomy |
315 |
|
|
|||||||
PEX syndrome |
219 |
|
pseudo-accommodation |
182, 252 |
reticular retinoschisis |
272 |
|
|||||||
